Supply Chain Map
CIK 924717

SURMODICS INC

EDGAR filings
Customers
1
1 disclosed
Suppliers
0
None disclosed
Largest customer
12%
MDT · FY to 2024-09-30
Named-customer revenue
$15.1M
1 customer · FY to 2024-09-30
Latest period
Sep 30, 2024
10-K filed 2024-11-20
SuppliersCustomersNo supplier discloses itMDT12% · $15.1MMDT · 12% of SURMODICS INC revenue · $15.1M · FY to 2024-09-30 · 10-K filed 2024-11-20SURMODICS INC
Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies SURMODICS INC discloses as major customers, as a share of SURMODICS INC revenue. 1 active, 0 lapsed.

Company% of SURMODICS INC revenueEst. revenuePeriodTrendStatusSource
MDT
Medtronic plc
 12%$15.1M FY 2024-09-30
FY ending 2012-09-30: 19%FY ending 2013-09-30: 19%FY ending 2014-09-30: 19%FY ending 2015-09-30: 26%FY ending 2016-09-30: 25%FY ending 2017-09-30: 18%FY ending 2018-09-30: 16%FY ending 2019-09-30: 14%FY ending 2020-09-30: 14%FY ending 2021-09-30: 13%FY ending 2022-09-30: 13%FY ending 2023-09-30: 10%FY ending 2024-09-30: 12%+2.0pp
Active 10-K 2024-11-20
Revenue from Abbott and Medtronic represented approximately 16% and 12%, respectively, of our consolidated revenue for fiscal 2024.
10-K filed 2024-11-20 Period FY 2023-10-01 to 2024-09-30 (12%)Accession 0000950170-24-129020
With respect to our Medical Device segment, revenue from Abbott and Medtronic represented approximately 20% and 16%, respectively, of our Medical Device segment revenue for fiscal 2024, and revenue from one additional customer represented approximately 10% of our Medical Device segment revenue for fiscal 2024.
10-K filed 2024-11-20 Period FY 2022-10-01 to 2023-09-30 (10%)Accession 0000950170-24-129020
For fiscal 2024, 2023 and 2022, the total amount of revenue recognized that was included in the respective beginning of fiscal year balances of deferred revenue on the consolidated balance sheets totaled $5.3 million, $4.6 million and $5.7 million, respectively.Revenue from customers that equaled or exceeded 10% of total revenue was as follows: Fiscal Year 2024 2023 2022 Abbott 16 % 27 % 11 % Medtronic 12 % 10 % 13 % Revenue by geographic region was as follows: Fiscal Year 2024 2023 2022 Domestic 83 % 82 % 74 % Foreign 17 % 18 % 26 %
10-K filed 2024-11-20 Period FY 2021-10-01 to 2022-09-30 (13%)Accession 0000950170-24-129020
For discussion of contract liability (deferred revenue) balances and remaining performance obligations, see Note 4 Collaborative Arrangement.68 TABLE OF CONTENTS Revenue from customers that equaled or exceeded 10% of total revenue was as follows: Fiscal Year 2023 2022 2021 Abbott 27 % 11 % 21 % Medtronic 10 % 13 % 13 % Revenue by geographic region was as follows: Fiscal Year 2023 2022 2021 Domestic 82 % 74 % 79 % Foreign 18 % 26 % 21 %
10-K filed 2023-11-22 Period FY 2020-10-01 to 2021-09-30 (13%)Accession 0000950170-23-065738
For discussion of contract liability (deferred revenue) balances and remaining performance obligations, see Note 4 Collaborative Arrangement.Revenue from customers that equaled or exceeded 10% of total revenue was as follows: Fiscal Year 2022 2021 2020 Abbott 11 % 21 % 19 % Medtronic 13 % 13 % 14 %
10-K filed 2022-11-23 Period FY 2019-10-01 to 2020-09-30 (14%)Accession 0000950170-22-025644
Medtronic 13 % 14 % 14 %
10-K filed 2021-11-24 Period FY 2018-10-01 to 2019-09-30 (14%)Accession 0001564590-21-058206
Medtronic 14 % 14 % 16 %
10-K filed 2020-12-02 Period FY 2017-10-01 to 2018-09-30 (16%)Accession 0001564590-20-055870
Medtronic plc (“Medtronic”) is the Company’s largest customer at approximately 16%, 18% and 25% of total consolidated revenue for the years ended September 30, 2018, 2017 and 2016, respectively.
10-K filed 2018-11-30 Period FY 2016-10-01 to 2017-09-30 (18%), FY 2015-10-01 to 2016-09-30 (25%)Accession 0001564590-18-030336
Medtronic plc (“Medtronic”) is the Company’s largest customer at approximately 18%, 25% and 26% of total consolidated revenue for the fiscal years ended September 30, 2017, 2016 and 2015, respectively.
10-K filed 2017-12-01 Period FY 2014-10-01 to 2015-09-30 (26%)Accession 0001564590-17-024465
Medtronic plc (“Medtronic”) is the Company’s largest customer at approximately 25%, 26% and 19% of total consolidated revenue for the fiscal years ended September 30, 2016, 2015 and 2014, respectively.
10-K filed 2016-12-02 Period FY 2013-10-01 to 2014-09-30 (19%)Accession 0001564590-16-029755
Medtronic 26 % 19 % 19 %
10-K filed 2015-12-04 Period FY 2012-10-01 to 2013-09-30 (19%)Accession 0001564590-15-011278
Medtronic 19 % 19 % 19 %
10-K filed 2014-12-05 Period FY 2011-10-01 to 2012-09-30 (19%)Accession 0001193125-14-434817

Unnamed major customers

Disclosed without names in the fiscal year ending 2019-09-30. Identities are not inferred.

  • Abbott19%
  • Medtronic10%

Alerts are coming

Get an email when SURMODICS INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.

We store only your email, the page you signed up from and the time. Privacy